Recombinant Hepatitis B Vaccine Market Report

Global and China Recombinant Hepatitis B Vaccine Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 18, 2022
  • PAGES：185
  • REPORT CODE：GMM1384662
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Hepatitis B Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Pfizer Inc

    • Johnson & Johnson

    • Dalian Hissen Bio-pharm

    • Sanofi Pasteur

    • Beijing Tiantan Biological

    • GlaxoSmithKline Plc

    • NCPC

    • Hualan Biological Engineering

    • CSL Limited

    • Serum Institute of India

    • China National Biotec Group

    • Merck

    • Emergent Biosolutions

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • 10mcg/ml

    • 10mcg/05ml

    Application:

    • Newborn

    • Primary School Students

    • Adult

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Recombinant Hepatitis B Vaccine Industry Overview

      • 1.1.1 Recombinant Hepatitis B Vaccine Market Scope and Market Segments

      • 1.1.2 Recombinant Hepatitis B Vaccine Industry Characteristics

      • 1.1.3 Global and China Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Recombinant Hepatitis B Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Recombinant Hepatitis B Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 10mcg/ml

      • 1.2.2 10mcg/05ml

    • 1.3 Global Recombinant Hepatitis B Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Newborn

      • 1.3.2 Primary School Students

      • 1.3.3 Adult

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Recombinant Hepatitis B Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Recombinant Hepatitis B Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Recombinant Hepatitis B Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Recombinant Hepatitis B Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Recombinant Hepatitis B Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Recombinant Hepatitis B Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Recombinant Hepatitis B Vaccine Industry PEST Analysis

    • 2.3 Recombinant Hepatitis B Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Recombinant Hepatitis B Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Recombinant Hepatitis B Vaccine Industry

    Chapter 3 Global and China Recombinant Hepatitis B Vaccine Market, by Manufacturer

    • 3.1 Global and China Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Recombinant Hepatitis B Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Recombinant Hepatitis B Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Recombinant Hepatitis B Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Recombinant Hepatitis B Vaccine Market Top 3 Players

    Chapter 4 Global and China Recombinant Hepatitis B Vaccine Market, by Type (2017-2028)

    • 4.1 Recombinant Hepatitis B Vaccine Market Trend, by Type

    • 4.2 Global Recombinant Hepatitis B Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Recombinant Hepatitis B Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Recombinant Hepatitis B Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Recombinant Hepatitis B Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China Recombinant Hepatitis B Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Recombinant Hepatitis B Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Recombinant Hepatitis B Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Recombinant Hepatitis B Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Recombinant Hepatitis B Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Recombinant Hepatitis B Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Recombinant Hepatitis B Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Recombinant Hepatitis B Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Recombinant Hepatitis B Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Recombinant Hepatitis B Vaccine Market Analysis

    • 7.1 North America Recombinant Hepatitis B Vaccine Market, by Type

    • 7.2 North America Recombinant Hepatitis B Vaccine Market, by Application

    • 7.3 North America Recombinant Hepatitis B Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Recombinant Hepatitis B Vaccine Market Analysis

    • 8.1 Europe Recombinant Hepatitis B Vaccine Market, by Type

    • 8.2 Europe Recombinant Hepatitis B Vaccine Market, by Application

    • 8.3 Europe Recombinant Hepatitis B Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Recombinant Hepatitis B Vaccine Market Analysis

    • 9.1 APAC Recombinant Hepatitis B Vaccine Market, by Type

    • 9.2 APAC Recombinant Hepatitis B Vaccine Market, by Application

    • 9.3 APAC Recombinant Hepatitis B Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Recombinant Hepatitis B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Recombinant Hepatitis B Vaccine Company Profiles

      • 11.1 Pfizer Inc

        • 11.1.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Pfizer Inc Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.1.3 Pfizer Inc Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Johnson & Johnson

        • 11.2.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.2.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Dalian Hissen Bio-pharm

        • 11.3.1 Dalian Hissen Bio-pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.3.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Sanofi Pasteur

        • 11.4.1 Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Beijing Tiantan Biological

        • 11.5.1 Beijing Tiantan Biological Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.5.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 GlaxoSmithKline Plc

        • 11.6.1 GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.6.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 NCPC

        • 11.7.1 NCPC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 NCPC Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.7.3 NCPC Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Hualan Biological Engineering

        • 11.8.1 Hualan Biological Engineering Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.8.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 CSL Limited

        • 11.9.1 CSL Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 CSL Limited Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.9.3 CSL Limited Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Serum Institute of India

        • 11.10.1 Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Serum Institute of India Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.10.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 China National Biotec Group

        • 11.11.1 China National Biotec Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Merck

        • 11.12.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Merck Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.12.3 Merck Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Emergent Biosolutions

        • 11.13.1 Emergent Biosolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Profiles, Application and Specification

        • 11.13.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Recombinant Hepatitis B Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 Recombinant Hepatitis B Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Recombinant Hepatitis B Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Market Size and Growth Rate of 10mcg/ml (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Market Size and Growth Rate of 10mcg/05ml (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Market Size and Growth Rate of Newborn (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Market Size and Growth Rate of Primary School Students (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Market Size and Growth Rate of Adult (2017-2028)

    • Figure North America Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Recombinant Hepatitis B Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Recombinant Hepatitis B Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Recombinant Hepatitis B Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Recombinant Hepatitis B Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China Recombinant Hepatitis B Vaccine Market Share, by Manufacturer in 2022

    • Table Global Recombinant Hepatitis B Vaccine Sales Volume, by Type (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Sales Value, by Type (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Price Trend, by Type (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Volume, by Type (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Value, by Type (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Price Trend, by Type (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Sales Volume, by Application (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Sales Value, by Application (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global Recombinant Hepatitis B Vaccine Sales Value Share, by Application (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Volume, by Application (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Value, by Application (2017-2028)

    • Table China Recombinant Hepatitis B Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America Recombinant Hepatitis B Vaccine Sales Volume, by Type (2017-2028)

    • Table North America Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America Recombinant Hepatitis B Vaccine Sales Volume, by Application (2017-2028)

    • Table North America Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe Recombinant Hepatitis B Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe Recombinant Hepatitis B Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC Recombinant Hepatitis B Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC Recombinant Hepatitis B Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Hepatitis B Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Recombinant Hepatitis B Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Recombinant Hepatitis B Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc Product Profiles, Application and Specification

    • Table Pfizer Inc Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dalian Hissen Bio-pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dalian Hissen Bio-pharm Product Profiles, Application and Specification

    • Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur Product Profiles, Application and Specification

    • Table Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beijing Tiantan Biological Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beijing Tiantan Biological Product Profiles, Application and Specification

    • Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NCPC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NCPC Product Profiles, Application and Specification

    • Table NCPC Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hualan Biological Engineering Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hualan Biological Engineering Product Profiles, Application and Specification

    • Table Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Limited Product Profiles, Application and Specification

    • Table CSL Limited Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute of India Product Profiles, Application and Specification

    • Table Serum Institute of India Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table China National Biotec Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table China National Biotec Group Product Profiles, Application and Specification

    • Table China National Biotec Group Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emergent Biosolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emergent Biosolutions Product Profiles, Application and Specification

    • Table Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US